Literature DB >> 10192784

BCL-2 transduction, using a herpes simplex virus amplicon, protects hippocampal neurons from transient global ischemia.

F J Antonawich1, H J Federoff, J N Davis.   

Abstract

Transient global ischemia results in selective neuronal damage of hippocampal CA1 neurons. Five minutes of bilateral common carotid artery occlusion, in the Mongolian gerbil, effectively restricts forebrain blood flow, resulting in a delayed neuronal death of CA1 pyramidal cells. While there is a delay of approximately 72 h in the appearance of cell death, markers related to the mechanism of ischemic death become apparent well before neurons die. Ischemia-induced increases in the cell-death-promoting protein, bax, may disrupt the bcl-2/bax ratio necessary for normal neuronal functioning and thus promote transient ischemic death. In order to locally maintain this critical bcl-2/bax ratio and thus protect CA1 neurons from delayed neuronal death, a herpes simplex viral (HSV) vector was used to selectively introduce human bcl-2, under the control of the herpes IE 4/5 promoter, into the CA1 region of the gerbil hippocampus. Twenty-four hours prior to ischemia surgery, 1 microl of HSVbcl-2 was infused unilaterally into the CA1 region at a rate of 2 nl/min. Seventy-two hours after ischemia the animals were sacrificed and processed using Nissl, silver degeneration, and immunohistochemical (anti-human bcl-2) staining. Immunohistochemistry demonstrated both glial and neuronal bcl-2 expression around the HSVbcl-2 infusion site. The evaluation following silver degeneration staining indicated a further degeneration of CA1 neurons in the immediate area of the viral vector infusion. This damage seems to be the result of cellular debris associated with the processing of the viral amplicons. Silver degeneration staining is not present in the areas that demonstrate bcl-2 staining. These neurons appear to have been rescued from ischemic damage. This result was confirmed using the Nissl staining. Therefore, by altering the local ratio of bcl-2/bax using the HSVbcl-2 vector one may protect CA1 pyramidal cell from the delayed neuronal death of transient global ischemia. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10192784     DOI: 10.1006/exnr.1998.7004

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  18 in total

1.  Sparing of neuronal function postseizure with gene therapy.

Authors:  J McLaughlin; B Roozendaal; T Dumas; A Gupta; O Ajilore; J Hsieh; D Ho; M Lawrence; J L McGaugh; R Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Effect of hemorrhagic shock on apoptosis and energy-dependent efflux system in the brain.

Authors:  Zhao-Ying Yu; Shinsuke Ono; Maria Spatz; Richard M McCarron
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

Review 3.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

4.  Anti-apoptotic therapy with a Tat fusion protein protects against excitotoxic insults in vitro and in vivo.

Authors:  Kevin L Ju; Nathan C Manley; Robert M Sapolsky
Journal:  Exp Neurol       Date:  2007-12-23       Impact factor: 5.330

Review 5.  Methods for gene transfer to the central nervous system.

Authors:  Boris Kantor; Rachel M Bailey; Keon Wimberly; Sahana N Kalburgi; Steven J Gray
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

6.  Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis.

Authors:  F J Northington; D M Ferriero; D L Flock; L J Martin
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

7.  Protection against ischemic brain injury by protein therapeutics.

Authors:  Sadamitsu Asoh; Ikuroh Ohsawa; Takashi Mori; Ken-Ichiro Katsura; Tomoharu Hiraide; Yasuo Katayama; Megumi Kimura; Daiya Ozaki; Kumi Yamagata; Shigeo Ohta
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-10       Impact factor: 11.205

8.  The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity.

Authors:  Erin K Golembewski; Samantha Q Wales; Laure Aurelian; Paul J Yarowsky
Journal:  Exp Neurol       Date:  2006-10-16       Impact factor: 5.330

Review 9.  Beyond anoxia: the physiology of metabolic downregulation and recovery in the anoxia-tolerant turtle.

Authors:  Sarah L Milton; Howard M Prentice
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2006-09-05       Impact factor: 2.320

10.  Herpes Virus Amplicon Vectors.

Authors:  Suresh de Silva; William J Bowers
Journal:  Viruses       Date:  2009-12-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.